Effect of β(2)-adrenergic receptor polymorphism on response to longacting β(2) agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

BACKGROUND: Combined long-acting β(2)-agonist and inhaled corticosteroid (LABA/ICS) therapy improves outcomes in many asthmatics. Some studies suggest that patients homozygous for arginine at the 16(th) amino-acid position of the β(2) adrenergic receptor (B16 Arg/Arg) benefit less than those with B1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wechsler, Michael E., Kunselman, Susan J., Chinchilli, Vernon M, Bleecker, Eugene, Boushey, Homer A., Calhoun, William J., Ameredes, Bill T., Castro, Mario, Craig, Timothy J, Denlinger, Loren, Fahy, John V., Jarjour, Nizar, Kazani, Shamsah, Kim, Sophia, Kraft, Monica, Lazarus, Stephen C., Lemanske, Robert F, Markezich, Amy, Martin, Richard J., Permaul, Perdita, Peters, Stephen P, Ramsdell, Joe, Sorkness, Christine A., Sutherland, E Rand, Szefler, Stanley J, Walter, Michael J, Wasserman, Stephen, Israel, Elliot
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914569/
https://ncbi.nlm.nih.gov/pubmed/19932356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)61492-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados